Traws Pharma (TRAW) Treasury Shares (2012 - 2024)

Traws Pharma (TRAW) posted quarterly Treasury Shares of $12472.2 for Q2 2024, down 99.93% quarter-over-quarter from $16.9 million in Q2 2013.

Traws Pharma (TRAW) Treasury Shares (2012 - 2024) Analysis & Trends

Traws Pharma (TRAW) has reported Treasury Shares for 3 consecutive years, with $12472.2 the latest figure, recorded in Q2 2024.

In Q2 2024, Treasury Shares changed N/A year-over-year to $12472.2; the TTM figure through Jun 2024 stood at $12472.2 (changed N/A YoY), while the FY2012 annual figure was $16.9 million, up 50.64% from the prior year.
Treasury Shares retreated to $12472.2 in Q2 2024 per TRAW's latest filing, from $16.9 million in the prior quarter.
Across five years, Treasury Shares topped out at $12472.2 in Q2 2024 and bottomed at $12472.2 in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	2.72 Mn
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	8.96 Mn
10	Traws Pharma	5.60 Mn	588,417.40	-	-

Download Data